Marketing-authorisation holder
Alexion Pharma GmbH
16 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder
16 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
16 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| KANUMA2 mg / ml · Solution | Sebelipase alfa | Canada | Marketed | 2018 |
| KOSELUGO10 mg · Capsule | Selumetinib | Canada | Marketed | 2023 |
| KOSELUGO25 mg · Capsule | Selumetinib | Canada | Marketed | 2023 |
| KOSELUGO GRANULES7.5 mg · Granules | Selumetinib | Canada | Authorised | |
| KOSELUGO GRANULES5 mg · Granules | Selumetinib | Canada | Authorised | |
| SOLIRIS10 mg / ml · Solution | Eculizumab | Canada | Marketed | 2009 |
| STRENSIQ40 mg / ml · Solution | Asfotase alfa | Canada | Authorised | |
| STRENSIQ40 mg / ml · Solution | Asfotase alfa | Canada | Marketed | 2016 |
| STRENSIQ100 mg / ml · Solution | Asfotase alfa | Canada | Marketed | 2016 |
| STRENSIQ40 mg / ml · Solution | Asfotase alfa | Canada | Marketed | 2016 |
| STRENSIQ40 mg / ml · Solution | Asfotase alfa | Canada | Marketed | 2015 |
| ULTOMIRIS1100 mg / 11 ml · Solution | Ravulizumab | Canada | Marketed | 2023 |
| ULTOMIRIS300 mg / 3 ml · Solution | Ravulizumab | Canada | Marketed | 2023 |
| VOYDEYA150 mg / dose · Tablet | Danicopan | Canada | Marketed | 2024 |
| VOYDEYA200 mg / dose · Tablet | Danicopan | Canada | Marketed | 2024 |
| ULTOMIRIS10 mg / ml · Solution | Ravulizumab | Canada | Cancelled | 2021 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 16 | 15 | 1 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.